VARIVAX (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the VARIVAX drug offered from Merck Sharp & Dohme Corp.. This Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Varicella Virus Vaccine Live |
| SUBSTANCE NAME: | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN |
| TYPE: | VACCINE |
| PHARMA CLASS: | Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1995-03-17 |
| END MARKETING DATE: | 0000-00-00 |
VARIVAX VACCINE Details:
| Item Description | VARIVAX from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1350([PFU]/.5mL) |
| START MARKETING DATE: | 1995-03-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-4826_57f23194-526d-47d5-b2d0-d5cf06c7b544 |
| PRODUCT NDC: | 0006-4826 |
| APPLICATION NUMBER: | BLA103552 |
Other VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:
